Nanotechnology-based platforms are being explored for the delivery of therapeutics directly to the lungs through inhalation. However, to ensure translational relevance between preclinical animal models and human applications, it is essential to accurately quantify and report the lung-deposited dose, rather than relying solely on the nominally administered dose.
- Lin Yang
- Lianyong Han
- Chunying Chen